Advertisement
U.S. markets closed
Advertisement

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
9,900.00-76.00 (-0.76%)
At close: 05:32PM GMT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9,976.00
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume12,402
Avg. Volume1,998,288
Market Cap155.195B
Beta (5Y Monthly)0.19
PE Ratio (TTM)33.00
EPS (TTM)3.00
Earnings DateFeb 08, 2024
Forward Dividend & Yield2.35 (2.35%)
Ex-Dividend DateAug 10, 2023
1y Target Est129.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for AZN.L

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Insider Monkey

      15 Hardest Countries to Get Citizenship in Europe

      In this article, we will explore the 15 hardest countries to get citizenship in Europe. You can skip our comprehensive analysis and proceed directly to the 5 Hardest Countries to Get Citizenship in Europe. Obtaining citizenship in European countries often entails strict criteria and requirements. Eligibility typically includes a minimum residency period, clean criminal record, […]

    • Reuters

      UPDATE 2-White House urges RSV immunization makers to meet demand

      Senior Biden administration officials met with the makers of RSV immunizations for children this week to underscore the need for manufacturers such as Sanofi and AstraZeneca to urgently meet demand as winter approaches, the White House said on Tuesday. At a meeting at the White House on Monday, officials and manufacturers also agreed to plan now to meet next year's demand for the immunizations targeting respiratory syncytial virus, which generally causes mild, cold-like symptoms but can develop into severe illness in infants and older adults.

    • Insider Monkey

      30 Countries with the Highest Quality of Life Heading into 2024

      In this article, we will look into the 30 countries with the highest quality of life heading into 2024. If you want to skip our detailed analysis you can go directly to the 5 Countries with the Highest Quality of Life Heading into 2024. Global Quality of Life: An Analysis Quality of life is a […]